Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Biochemical and Biophysical Research Communications|January 17, 2012
Influence of heart failure on nucleolar organization and protein expression in human heartsEsther Roselló-Lletí, Miguel Rivera, Raquel Cortés, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2011
Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancerRafael Sirera, Roy M Bremnes, Andrea Cabrera, et al.
Revista Espanola De Cardiologia|October 6, 2006
[Myocardial remodeling and immunologic activation in patients with heart failure]Miguel Rivera, Raquel Taléns-Visconti, Alejandro Jordán, et al.
Annals of Surgical Oncology|October 23, 2013
A gene signature combining the tissue expression of three angiogenic factors is a prognostic marker in early-stage non-small cell lung cancerElena Sanmartín, Rafael Sirera, Marta Usó, et al.
European Journal of Heart Failure|November 24, 2004
Soluble TNF-alpha and interleukin-6 receptors in the urine of heart failure patients. Their clinical value and relationship with plasma levelsMiguel Rivera, Raquel Taléns-Visconti, Rafael Sirera, et al.
Critical Reviews in Oncology/Hematology|April 22, 2017
FGFR a promising druggable target in cancer: Molecular biology and new drugsRut Porta, Roberto Borea, Andreia Coelho, et al.
Cancers|June 2, 2021
Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung CancerFeiyu Zhang, Macarena Ferrero, Ning Dong, et al.
Oncotarget|July 28, 2016
Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markersMarta Usó, Eloisa Jantus-Lewintre, Roy M Bremnes, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 18, 2011
Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04)Vega Iranzo, Rafael Sirera, Alfredo Carrato, et al.
Lung Cancer (Amsterdam, Netherlands)|May 28, 2011
Fifth Educational Symposium of the Spanish Lung Cancer Group: report on the Molecular Biology WorkshopIsabel Bover, Christian Rolfo, Eloisa Jantus-Lewintre, et al.
Pageof 7